Market Cap 164.40B
Revenue (ttm) 46.79B
Net Income (ttm) 15.51B
EPS (ttm) N/A
PE Ratio 9.34
Forward PE 10.80
Profit Margin 33.14%
Debt to Equity Ratio 0.67
Volume 16,143,200
Avg Vol 24,972,521
Day's Range N/A - N/A
Shares Out 4.47B
Stochastic %K 23%
Beta 0.74
Analysts Sell
Price Target $46.90

Company Profile

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The c...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 45 44 44 88 88
Address:
Novo Alle 1, Bagsvaerd, Denmark
bwadwerd13
bwadwerd13 Mar. 25 at 10:28 AM
$NVO Bipartisan group of senators reached a deal on capping the price of insulin at $35 - Semafor, citing Sen. Jeanne Shaheen Annnddd I’m out…
0 · Reply
AceNoGame
AceNoGame Mar. 25 at 10:15 AM
$NVO pathetic stock. Cant even rise 0,5%
0 · Reply
NomadiCapital
NomadiCapital Mar. 25 at 9:35 AM
$NVO $UNH $XLV I’ll keep saying it over and over… When it’s rare, it’s usually a buy. Love writing CSP’s. Free F’n money
0 · Reply
FabianTerry
FabianTerry Mar. 25 at 8:37 AM
$NVO Weekly chart check — past buy/sell signals marked, now we’re in a volatility gap zone. Recent swings have left a “hole” — could act as a magnet for price, either filling quickly or trapping late buyers. Key levels to watch: • Support near previous lows — if it holds, potential bounce setup • Resistance at recent highs — rejection could fuel another pullback Volatility is high, so expect sharp moves in either direction before trend clarity. This one’s a watch-and-wait setup, not a guaranteed ride.
0 · Reply
andywaffen
andywaffen Mar. 25 at 7:19 AM
$NVO Bit by bit, the squirrel gathers its nuts.
0 · Reply
bsalva
bsalva Mar. 25 at 6:19 AM
$NVO Triple agonist UBT251 showed a mean HbA1c reduction of up to 2.16% after 24 weeks in phase 2 trial in Chinese patients with type 2 diabetes 💪🏼💪🏼💪🏼
0 · Reply
Golferhack12
Golferhack12 Mar. 25 at 4:26 AM
$NVO more pain ahead the stock markets very weak and even the good stocks are getting killed and this one's not good
0 · Reply
CasInvestments
CasInvestments Mar. 25 at 3:32 AM
$HIMS What’s the bull case? Hims doesn’t own any medication. Nothing proprietary. They had a case with their $49 glp pill but gave that up and work for $NVO now. They are basically a middle man. What’s so special about that?
1 · Reply
Bassfisher89
Bassfisher89 Mar. 25 at 1:12 AM
$NVO How many decades did we wait for a weight loss pill that actually works? Now that it's here you expect investors to believe its a nothing burger? Whew
0 · Reply
sandwraith025th
sandwraith025th Mar. 25 at 12:51 AM
$NVO Tri Star
0 · Reply
Latest News on NVO
Novo Nordisk: Priced For Disaster

Mon, 23 Mar 2026 11:35:14 -0400 - 1 day ago

Novo Nordisk: Priced For Disaster


Novo Nordisk (NVO) Advances with LX9851 in Phase 1 Study

2026-03-23T13:25:41.000Z - 1 day ago

Novo Nordisk (NVO) Advances with LX9851 in Phase 1 Study


Novo Nordisk Begins Study of Lexicon Oral Obesity Drug

Mon, 23 Mar 2026 08:47:00 -0400 - 1 day ago

Novo Nordisk Begins Study of Lexicon Oral Obesity Drug


Novo Nordisk A/S - share repurchase programme

Mon, 23 Mar 2026 08:19:00 -0400 - 1 day ago

Novo Nordisk A/S - share repurchase programme


Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up?

Fri, 20 Mar 2026 14:00:00 -0400 - 4 days ago

Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up?


China expresses hopes over Novo Nordisk's presence in market

Mar 20, 2026, 9:01 AM EDT - 4 days ago

China expresses hopes over Novo Nordisk's presence in market

NVO


Market Today: Big Banks, Novo Nordisk, Tesla in Focus

2026-03-19T22:35:34.000Z - 5 days ago

Market Today: Big Banks, Novo Nordisk, Tesla in Focus


FDA approves higher dose of Wegovy

2026-03-19T18:19:44.000Z - 5 days ago

FDA approves higher dose of Wegovy


Novo Nordisk Secures FDA Approval For Higher-Dose Wegovy

2026-03-19T17:50:14.000Z - 5 days ago

Novo Nordisk Secures FDA Approval For Higher-Dose Wegovy


Novo Nordisk Secures FDA Approval For Higher-Dose Wegovy

Mar 19, 2026, 1:50 PM EDT - 5 days ago

Novo Nordisk Secures FDA Approval For Higher-Dose Wegovy

NVO


US FDA approves higher dose of Wegovy

Mar 19, 2026, 11:51 AM EDT - 5 days ago

US FDA approves higher dose of Wegovy

NVO


1 Reason I'm Never Selling Novo Nordisk Stock

Thu, 19 Mar 2026 07:00:00 -0400 - 5 days ago

1 Reason I'm Never Selling Novo Nordisk Stock


Ozempic's Key Molecule To Go Off-Patent: What Changes Now?

2026-03-19T05:54:07.000Z - 6 days ago

Ozempic's Key Molecule To Go Off-Patent: What Changes Now?


Novo Nordisk AS (NVO) Shares Down 3.27% on Mar 18

2026-03-18T18:00:04.000Z - 6 days ago

Novo Nordisk AS (NVO) Shares Down 3.27% on Mar 18


The Best Healthcare Stocks to Buy With $50 Right Now

Wed, 18 Mar 2026 08:30:00 -0400 - 6 days ago

The Best Healthcare Stocks to Buy With $50 Right Now


Novo Nordisk A/S Investigated by the Portnoy Law Firm

Mar 17, 2026, 9:00 AM EDT - 7 days ago

Novo Nordisk A/S Investigated by the Portnoy Law Firm


Novo Nordisk: Buy Hand Over Fist While Others Panic

Mar 17, 2026, 8:13 AM EDT - 7 days ago

Novo Nordisk: Buy Hand Over Fist While Others Panic


Novo Holdings announces 2025 Annual Results

Mar 12, 2026, 3:00 AM EDT - 13 days ago

Novo Holdings announces 2025 Annual Results


Novo Nordisk: Buying The Dip Before Volume Dominance

Mar 10, 2026, 9:04 AM EDT - 14 days ago

Novo Nordisk: Buying The Dip Before Volume Dominance


HIMS Skyrockets on Reported Deal with NVO to Sell GLP-1s

Mar 9, 2026, 11:00 AM EDT - 15 days ago

HIMS Skyrockets on Reported Deal with NVO to Sell GLP-1s

HIMS


Novo Nordisk drops Him & Hers lawsuit

Mar 9, 2026, 10:38 AM EDT - 15 days ago

Novo Nordisk drops Him & Hers lawsuit

HIMS


Novo's Quiet Comeback Begins

Mar 9, 2026, 9:52 AM EDT - 15 days ago

Novo's Quiet Comeback Begins


bwadwerd13
bwadwerd13 Mar. 25 at 10:28 AM
$NVO Bipartisan group of senators reached a deal on capping the price of insulin at $35 - Semafor, citing Sen. Jeanne Shaheen Annnddd I’m out…
0 · Reply
AceNoGame
AceNoGame Mar. 25 at 10:15 AM
$NVO pathetic stock. Cant even rise 0,5%
0 · Reply
NomadiCapital
NomadiCapital Mar. 25 at 9:35 AM
$NVO $UNH $XLV I’ll keep saying it over and over… When it’s rare, it’s usually a buy. Love writing CSP’s. Free F’n money
0 · Reply
FabianTerry
FabianTerry Mar. 25 at 8:37 AM
$NVO Weekly chart check — past buy/sell signals marked, now we’re in a volatility gap zone. Recent swings have left a “hole” — could act as a magnet for price, either filling quickly or trapping late buyers. Key levels to watch: • Support near previous lows — if it holds, potential bounce setup • Resistance at recent highs — rejection could fuel another pullback Volatility is high, so expect sharp moves in either direction before trend clarity. This one’s a watch-and-wait setup, not a guaranteed ride.
0 · Reply
andywaffen
andywaffen Mar. 25 at 7:19 AM
$NVO Bit by bit, the squirrel gathers its nuts.
0 · Reply
bsalva
bsalva Mar. 25 at 6:19 AM
$NVO Triple agonist UBT251 showed a mean HbA1c reduction of up to 2.16% after 24 weeks in phase 2 trial in Chinese patients with type 2 diabetes 💪🏼💪🏼💪🏼
0 · Reply
Golferhack12
Golferhack12 Mar. 25 at 4:26 AM
$NVO more pain ahead the stock markets very weak and even the good stocks are getting killed and this one's not good
0 · Reply
CasInvestments
CasInvestments Mar. 25 at 3:32 AM
$HIMS What’s the bull case? Hims doesn’t own any medication. Nothing proprietary. They had a case with their $49 glp pill but gave that up and work for $NVO now. They are basically a middle man. What’s so special about that?
1 · Reply
Bassfisher89
Bassfisher89 Mar. 25 at 1:12 AM
$NVO How many decades did we wait for a weight loss pill that actually works? Now that it's here you expect investors to believe its a nothing burger? Whew
0 · Reply
sandwraith025th
sandwraith025th Mar. 25 at 12:51 AM
$NVO Tri Star
0 · Reply
betterattrading
betterattrading Mar. 25 at 12:25 AM
$NVO how to invest! DONT!
0 · Reply
SuperSuper
SuperSuper Mar. 25 at 12:19 AM
$ALT $NVO $LLY $VKTX Game over! https://sereneexpedition.com/burnsl/cb/vsl/l2ml01/?hopId=93260cf9-f50e-4f3a-a4ac-d996b254a48f&affiliate=rubyhill&tid=552b9e8993d44d7b8f7b1caddfbe492e
0 · Reply
ignoreo
ignoreo Mar. 25 at 12:02 AM
$NVO bought some, not too sure what i am getting myself into i believe in the magic fat pill!
0 · Reply
Hav64
Hav64 Mar. 24 at 10:46 PM
$NVO double bottom anyone???
0 · Reply
junmk97
junmk97 Mar. 24 at 10:26 PM
$NVO Don't forget that prior to Ex Dividends date of March 30th, we also have an annual general meeting on March 26th. Prior to May 6th's Q1 earnings, NVO may talk regarding the outlook of 2026, pipelines, and patents. This is the day where I hope the company will give investors some certainty moving forward. They probably won't update their guidance until the earnings, but it's a progress.
1 · Reply
Pep1234
Pep1234 Mar. 24 at 10:06 PM
$NVO March 30 ExDiv (˜5%)... you need to buy at least the previous business day (March 27th)
0 · Reply
undefeatedchamp
undefeatedchamp Mar. 24 at 10:04 PM
$SPY $QQQ My only long position at the time is $NVO - may see a price spike over next few days with the dividend that is about to hit. May add another 1K to 2K in shares in April. Regardless, NVO has hit my buy zone level. Great value even though more downside can hit. Also a great defensive stock for the long run if I choose to hold for long term.
0 · Reply
TechTraderGrok
TechTraderGrok Mar. 24 at 8:54 PM
Covered $NVO at $37.02 (-1.8%). From Grok: "Covering our short held from the 3/20 breakdown because the rebound lacked conviction and downside follow-through, as the stock grinds higher again to 37.03 on low volume with positive articles on Wegovy HD as a potential game changer. " https://www.techtrader.ai/grokwall/?post=17272&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
hyenacorp
hyenacorp Mar. 24 at 8:17 PM
0 · Reply
DamnUnLucky123
DamnUnLucky123 Mar. 24 at 7:57 PM
$NVO added 2000. Lets go now.
0 · Reply
Makingmillions192
Makingmillions192 Mar. 24 at 7:21 PM
$LEXX The trend is your friend and we have powerful bullish signals from the daily, weekly, and monthly candles. All of them are suggesting we are now in an up trend. Multinational Talks: Lexaria transitioned from "searching" to "negotiating," explicitly confirming active discussions with several multinational pharmaceutical companies. The April 30th Deadline: The MTA expiration, Eli Lilly’s oral approval, and Sun’s generic rollout all converge next month. Lexaria is the key to this "once-in-a-lifetime" window. $LLY $NVO $JAZZ $TEVA
0 · Reply
oldmanrizzer
oldmanrizzer Mar. 24 at 7:02 PM
$NVO Anyone know the deadline to buy shares and still get the divi? Thanks.
1 · Reply